Articles / CovidSafe tracking app reviewed
writer
Lecturer in Information and Communication Technologies, CQUniversity Australia
0 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
About 1.13 million people had downloaded the federal government’s COVIDSafe app by 6am today, just 12 hours after its release last night, said Health Minister Greg Hunt. The government is hoping at least 40% of the population will make use of the app, designed to help reduce the spread of the coronavirus disease.
Previously dubbed TraceTogether – in line with a similar app rolled out in Singapore – the coronavirus contact tracing app has been an ongoing cause of contention among the public. Many people have voiced concerns of an erosion of privacy, and potential misuse of citizen data by the government.
But how does COVIDSafe work? And to what extent has the app addressed our privacy concerns?
Menopausal Hormone Therapy - What Dose of Estrogen is Best?
Cardiovascular Benefits of GLP1s – New Evidence
Oral Contraceptive Pill in Teens
RSV and the Heart
writer
Lecturer in Information and Communication Technologies, CQUniversity Australia
Modified but kept in place
Eliminated entirely without replacement
Maintained as is
Completely replaced with an alternative system
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease